2014
Randomized open-label phase 2 study of MM-111 and paclitaxel (PTX) with trastuzumab (TRAS) in patients with HER2-expressing carcinomas of the distal esophagus, gastroesophageal (GE) junction, and stomach who have failed front-line metastatic or locally advanced therapy.
Denlinger C, Sym S, Bendell J, Alsina M, Watkins D, Chao Y, Cubillo A, Kunz P, Sun W, Baeksgaard L, Chen L, Horgan K, Frye S, Kudla A, McDonagh C, Czibere A, Moyo V, Chibaudel B, Bang Y. Randomized open-label phase 2 study of MM-111 and paclitaxel (PTX) with trastuzumab (TRAS) in patients with HER2-expressing carcinomas of the distal esophagus, gastroesophageal (GE) junction, and stomach who have failed front-line metastatic or locally advanced therapy. Journal Of Clinical Oncology 2014, 32: tps4148-tps4148. DOI: 10.1200/jco.2014.32.15_suppl.tps4148.Peer-Reviewed Original Research
2011
A rare case of an aldosterone secreting metastatic adrenocortical carcinoma and papillary thyroid carcinoma in a 31-year-old male
Wanta SM, Basina M, Chang SD, Chang DT, Ford JM, Greco R, Kingham K, Merritt RE, Kunz PL. A rare case of an aldosterone secreting metastatic adrenocortical carcinoma and papillary thyroid carcinoma in a 31-year-old male. Rare Tumors 2011, 3: e45. PMID: 22355500, PMCID: PMC3282450, DOI: 10.4081/rt.2011.e45.Peer-Reviewed Original ResearchPapillary thyroid carcinomaMetastatic adrenocortical carcinomaAdrenocortical carcinomaThyroid carcinomaLarge left adrenal massMultiple endocrine neoplasia type ILeft adrenal massRare synchronous presentationRight upper lungAdjuvant radiation therapyLi-Fraumeni syndromeGene mutation analysisACC resectionRefractory hypertensionUpper lungBrain metastasesAdrenal massesLeft lobeRare caseRadiation therapySynchronous presentationCarcinomaMenin geneSimilar casesType I